Correlation Between Acrivon Therapeutics, and Pmv Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Acrivon Therapeutics, and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Pmv Pharmaceuticals.
Diversification Opportunities for Acrivon Therapeutics, and Pmv Pharmaceuticals
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Acrivon and Pmv is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Pmv Pharmaceuticals go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Pmv Pharmaceuticals
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 1.2 times more return on investment than Pmv Pharmaceuticals. However, Acrivon Therapeutics, is 1.2 times more volatile than Pmv Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 1,262 in Acrivon Therapeutics, Common on August 28, 2024 and sell it today you would lose (546.00) from holding Acrivon Therapeutics, Common or give up 43.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Pmv Pharmaceuticals
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Pmv Pharmaceuticals |
Acrivon Therapeutics, and Pmv Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Pmv Pharmaceuticals
The main advantage of trading using opposite Acrivon Therapeutics, and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. HCW Biologics | Acrivon Therapeutics, vs. Scpharmaceuticals | Acrivon Therapeutics, vs. Milestone Pharmaceuticals |
| Pmv Pharmaceuticals vs. Eliem Therapeutics | Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |